Management of hypoparathyroidism: summary statement and guidelines

ML Brandi, JP Bilezikian, D Shoback… - The Journal of …, 2016 - academic.oup.com
Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent
or deficient PTH. This report presents a summary of current information about epidemiology …

Hypoparathyroidism

M Mannstadt, JP Bilezikian, RV Thakker… - Nature Reviews …, 2017 - nature.com
Hypoparathyroidism is a disease characterized by inadequately low circulating
concentrations of parathyroid hormone (PTH) resulting in low calcium levels and increased …

Presentation of hypoparathyroidism: etiologies and clinical features

DM Shoback, JP Bilezikian, AG Costa… - The Journal of …, 2016 - academic.oup.com
Context: Understanding the etiology, diagnosis, and symptoms of hypoparathyroidism may
help to improve quality of life and long-term disease outcomes. This paper summarizes the …

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research

JP Bilezikian, A Khan, JT Potts Jr… - Journal of Bone and …, 2011 - academic.oup.com
Recent advances in understanding the epidemiology, genetics, diagnosis, clinical
presentations, skeletal involvement, and therapeutic approaches to hypoparathyroidism led …

Long-term follow-up of patients with hypoparathyroidism

DM Mitchell, S Regan, MR Cooley… - The Journal of …, 2012 - academic.oup.com
Context: Despite tremendous interest in hypoparathyroidism, large cohort studies describing
typical treatment patterns, laboratory parameters, and rates of complications are lacking …

Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 …

M Mannstadt, BL Clarke, T Vokes… - The lancet Diabetes & …, 2013 - thelancet.com
Background Hypoparathyroidism results in impaired mineral homoeostasis, including
hypocalcaemia and hyperphosphataemia. Treatment with high-dose oral calcium and active …

Management of hypoparathyroidism: present and future

JP Bilezikian, ML Brandi, NE Cusano… - The Journal of …, 2016 - academic.oup.com
Context: Conventional management of hypoparathyroidism has focused upon maintaining
the serum calcium with oral calcium and active vitamin D, often requiring high doses and …

Long-Term Treatment of Hypoparathyroidism: A Randomized Controlled Study Comparing Parathyroid Hormone-(1–34) Versus Calcitriol and Calcium

KK Winer, CW Ko, JC Reynolds… - The Journal of …, 2003 - academic.oup.com
Hypoparathyroidism is one of the few remaining hormonal insufficiency states for which
replacement therapy is unavailable. Previous short-term controlled trials have shown PTH to …

Hypocalcemia: updates in diagnosis and management for primary care

J Fong, A Khan - Canadian family physician, 2012 - cfp.ca
Objective To provide family physicians with an evidence-based approach to the diagnosis
and management of hypocalcemia. Quality of evidence MEDLINE and EMBASE articles …

[HTML][HTML] Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic …

KK Winer, B Zhang, JA Shrader… - The Journal of …, 2011 - pmc.ncbi.nlm.nih.gov
Context: Vitamin D therapy for hypoparathyroidism does not restore PTH-dependent renal
calcium reabsorption, which can lead to renal damage. An alternative approach, PTH 1-34 …